YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Strattera

FDA to examine new ways to study ADD drugs

Jan 4, 2006 | AP
Reports of sudden deaths, strokes, heart attacks and hypertension in both children and adults taking drugs to treat attention deficit hyperactivity...

Lilly Agrees to Add Warning On Strattera Labeling

Oct 21, 2005 | Psychiatric News
A pharmaceutical maker volunteers to add a black-box warning noting rare occurrences of suicidal thoughts in young patients taking its popular ADHD...

ADHD Drug, Straterra, May Cause Suicidal Thoughts

Sep 29, 2005 | www.Newsinferno.com
Eli Lilly & Company is warning that its ADHD drug, Straterra, may cause suicidal thoughts in children and adolescents.  In a press release...

FDA Issues Public Health Advisory on Strattera (Atomoxetine) for Attention Deficit Disorder

Aug 29, 2005 | www.fda.gov
The Food and Drug Administration (FDA) today is issuing a Public Health Advisory to alert physicians of reports of suicidal thinking in children and...

FDA ISSUES WARNING TO ELI LILLY WITH RESPECT TO TELEVISION AD FOR STRATTERA, A DRUG USED TO TREAT ADHD (ATTENTION DEFICIT HYPERACTIVITY DISORDER)

Jun 17, 2005 | www.Newsinferno.com
In a letter to Eli Lilly, the FDA has warned the pharmaceutical giant that its television advertisement for Strattera “is false or misleading...

LILLY ADDS WARNING TO STRATTERA LABEL

Dec 20, 2004 | www.pharmexec.com
Eli Lilly and Co. announced it has added a bolded warning to the product label for Strattera (atomoxetine hydrochloride) regarding two reported cases...

Strattera to Get New Risk Label

Dec 18, 2004 | AP
Strattera, used to treat attention-deficit hyperactivity disorder, is getting an updated label to highlight the risk the drug might contribute to...

Eli Lilly Off on Drug Label Warning

Dec 17, 2004 | www.thestreet.com
Eli Lilly shares fell Friday after the company said it has added a bolded warning to the product label for Strattera, its treatment for attention...

Page 2/2 [first] [prev] 1 2 [next] [last]

Strattera
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News